Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2026)
Caris Life Sciences (CAI) posted quarterly Interest & Investment Income of $6.8 million for Q1 2026, up 1258.65% year-over-year from $503000.0 in Q1 2025, and down 2.58% quarter-over-quarter from $7.0 million in Q4 2025.
Caris Life Sciences (CAI) Interest & Investment Income (2024 - 2026) Analysis & Trends
Caris Life Sciences' Interest & Investment Income history runs 3 years deep, the most recent figure standing at $6.8 million for Q1 2026.
- In Q1 2026, Interest & Investment Income rose 1258.65% year-over-year to $6.8 million; the TTM figure through Mar 2026 stood at $22.8 million (up 289.74% YoY), while the FY2025 annual figure was $16.5 million, up 131.63% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $6.8 million, down from $7.0 million in the prior quarter.
- The five-year high for Interest & Investment Income was $7.4 million in Q3 2025, with the low at $503000.0 in Q1 2025.
- The 3-year median for Interest & Investment Income is $2.2 million (2024), against an average of $3.6 million.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income slumped 38.71% in 2025, then soared 1258.65% in 2026.
- Caris Life Sciences' Interest & Investment Income stood at $970000.0 in 2024, then soared by 623.2% to $7.0 million in 2025, then retreated by 2.58% to $6.8 million in 2026.
- Business Quant data shows CAI's Interest & Investment Income at $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $7.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Caris Life Sciences | 6.16 Bn | 5.37 Bn | 182.38 Mn | 6.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.82 Mn |
| Mar 31, 2026 | 6.83 Mn |
| Dec 31, 2025 | 7.02 Mn |
| Sep 30, 2025 | 7.36 Mn |
| Jun 30, 2025 | 1.62 Mn |
| Mar 31, 2025 | 503,000.00 |
| Dec 31, 2024 | 970,000.00 |
| Sep 30, 2024 | 1.74 Mn |
| Jun 30, 2024 | 2.64 Mn |